Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

COVID-19

Free Subscription Articles published in Zhonghua Jie He He Hu Xi Za Zhi Retrieve available abstracts of 110 articles: HTML format

Single Articles

April 2024
1. SUN ZZ, Sun GF, Zhuang R, Zhu LQ, et al
   [Best evidence summary for awake prone positioning in treating hypoxemic due to COVID-19 infection].
   Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:313-318.
   PubMed     Abstract available
   
   
   March 2024
2. GAO HB, Zhang J
   [Analysis of prognostic factors in patients with COVID-19 infection].
   Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:296-300.
   PubMed     Abstract available
   
   
   
3. GUO JW, Xiao Y
   [Impact of COVID-19 on the treatment of sleep medicine].
   Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:292-296.
   PubMed     Abstract available
   
   
   
4. YU D, Huang WQ, Zhan YZ, Xiao GH, et al
   [Diaphragmatic dysfunction post-COVID-19 infection: report of two cases].
   Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:244-248.
   PubMed     Abstract available
   
   
   
5. CHEN RX, Mai YL, Shen KN, Zhang T, et al
   [A case of follicular lymphoma with recurrent fever and pulmonary infiltrates].
   Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:222-227.
   PubMed     Abstract available
   
   
   February 2024
6. ZHA SS, He ZF, Guan LL, Niu JY, et al
   [Clinical research progress in non-invasive positive pressure ventilation in 2023].
   Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:146-151.
   PubMed     Abstract available
   
   
   
7. SHI YJ, Chen RX, Liu XN, Shao C, et al
   [Clinical analysis of COVID-19 in patients with preexisting interstitial lung abnormalities].
   Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:126-131.
   PubMed     Abstract available
   
   
   December 2023
8. WANG SY, Wang YM, Liu M, Zhao L, et al
   [Migratory pulmonary ground glass opacities caused by SARS-CoV-2 infection in a patient on B-cell depletion therapy].
   Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:1233-1239.
   PubMed     Abstract available
   
   
   
9. 
   [Expert consensus on the management of interstitial lung disease during the COVID-19 epidemic].
   Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:1204-1218.
   PubMed     Abstract available
   
   
   
10. 
    [Expert consensus on diagnosis and treatment of severe COVID-19 associated with pulmonary aspergillus and mucormycosis].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;47:10-23.
    PubMed     Abstract available
    
    
    November 2023
11. HAN L, Sun LX, Chen YL, Shao HJ, et al
    [Clinical characteristics of a case of severe pneumonia caused by coinfection of COVID-19 and Chlamydia Psittaci].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:1118-1120.
    PubMed     Abstract available
    
    
    September 2023
12. 
    [Expert consensus on the diagnosis and management of Birt-Hogg-Dube syndrome].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:897-908.
    PubMed     Abstract available
    
    
    August 2023
13. HUANG LX, Liang YD, Wang YQ, Li JT, et al
    [Hemophagocytic syndrome secondary to COVID-19: a case report and literature review].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:791-796.
    PubMed     Abstract available
    
    
    May 2023
14. HUANG H
    [Comments on the systemic corticosteroid strategy for the coronavirus disease 2019 (COVID-19)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:521-524.
    PubMed     Abstract available
    
    
    
15. CHENG LL, Li SY, Zhong NS
    [New characteristics of COVID-19 caused by the Omicron variant in Guangzhou].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:441-443.
    PubMed     Abstract available
    
    
    April 2023
16. SU Y, Cao Y, Wang RL, Dong EJ, et al
    [Progress on specific and non-specific immune effects of Bacille Calmette-Guerin].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:413-418.
    PubMed     Abstract available
    
    
    February 2023
17. 
    [Expert consensus on off-label administration of drugs in COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:1-10.
    PubMed     Abstract available
    
    
    
18. 
    [Thromboprophylaxis and management of anticoagulation in hospitalized patients with COVID-19: clinical pathway and practices].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:1-16.
    PubMed     Abstract available
    
    
    
19. TONG ZH, Jiang HY, Chen YS
    [Annual progress in pulmonary rehabilitation 2022].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:172-176.
    PubMed     Abstract available
    
    
    
20. YANG QY, Qu JM
    [Annual update of pulmonary infectious diseases in 2022].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:168-171.
    PubMed     Abstract available
    
    
    January 2023
21. 
    [Expert consensus on the diagnosis and treatment of SARS-CoV-2-associated cough].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:E002.
    PubMed     Abstract available
    
    
    
22. ZHA SS, He ZF, Guan LL, Niu JY, et al
    [Clinical update in non-invasive positive pressure ventilation for respiratory failure in 2022].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:77-81.
    PubMed     Abstract available
    
    
    
23. PAN P, Xie LX
    [Clinical update in critical care of pulmonary medicine 2022].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:72-76.
    PubMed     Abstract available
    
    
    
24. 
    [Expert consensus on treatment of severe COVID-19 caused by Omicron variants].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:E001.
    PubMed     Abstract available
    
    
    December 2022
25. LI Y, Liu SY, Zheng JP
    [Chest imaging-based artificial intelligence in the diagnosis of coronavirus disease 2019 and prospects for future research].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:1255-1260.
    PubMed     Abstract available
    
    
    
26. SHANG FQ, Chen H, Yang X, Wu MJ, et al
    [Clinical characteristics of patients infected with 2019-nCoV Omicron variants BA.2 and BA.5 in Xi'an city, China].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:1199-1203.
    PubMed     Abstract available
    
    
    August 2022
27. LONG QY, Zheng YL, Gao Z
    [Advances in SARS-CoV-2 diagnostic strategies during the later COVID-19 era].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:819-825.
    PubMed     Abstract available
    
    
    July 2022
28. CAI YQ, Zeng HQ, Li YP, Li NS, et al
    [Advances in clinical prediction scores for prognosis of coronavirus disease-2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:706-711.
    PubMed     Abstract available
    
    
    June 2022
29. LIU J, Wu JL, Liu GC, Jiang P, et al
    [Research progress on physiological changes caused by wearing N95 mask in patients with chronic obstruction pulmonary disease].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:598-602.
    PubMed     Abstract available
    
    
    
30. XU FY, Zhai ZG
    [Annual review of venous thromboembolism in 2021].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:588-592.
    PubMed     Abstract available
    
    
    May 2022
31. TENG PK, Han XD, Liu YZ, Zhao WY, et al
    [Clinical characteristics and outcome analysis of COVID-19 patients with pulmonary tuberculosis].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:510-514.
    PubMed     Abstract available
    
    
    April 2022
32. 
    [Chinese expert consensus on the use of Omalizumab in allergic asthma (2021 version)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:341-354.
    PubMed     Abstract available
    
    
    
33. SUN YC
    [Focus on influenza vaccination in patients with chronic obstructive pulmonary disease].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:333-334.
    PubMed     Abstract available
    
    
    January 2022
34. SONG LC, Xie LX
    [Clinical update in critical care of pulmonary medicine 2021].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:83-87.
    PubMed     Abstract available
    
    
    
35. ZHA SS, He ZF, Guan LL, Niu JY, et al
    [Clinical research progress in non-invasive positive pressure ventilation from 2020 to 2021].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:72-77.
    PubMed     Abstract available
    
    
    
36. ZHOU M, Qu JM
    [Update on COVID-19 in 2021].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:67-71.
    PubMed     Abstract available
    
    
    November 2021
37. SUN JW, Cui ZF, Li FJ, Liu MY, et al
    [Epidemiological characteristics of novel coronavirus pneumonia in Shijiazhuang, China].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:961-965.
    PubMed     Abstract available
    
    
    September 2021
38. LONG QY, Zheng YL, Gao ZC
    [Analysis of the clinical characteristics of COVID-19 reinfection cases].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:793-799.
    PubMed     Abstract available
    
    
    August 2021
39. SU B, Song Y, Hu K
    [Management strategies for obstructive sleep apnea under the normalized prevention and control of the novel coronavirus pneumonia epidemic].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:741-745.
    PubMed    
    
    
    May 2021
40. WANG L, Fan JP, Xu Y, Wang JL, et al
    [Progress and challenge of COVID-19 vaccine development].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:492-496.
    PubMed    
    
    
    
41. LIU B, Wang P, Yang DX, Xiong WN, et al
    [Development of multiple organ dysfunction syndrome in patients with Coronavirus Disease 2019: clinical characteristics and risk factors].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:435-442.
    PubMed     Abstract available
    
    
    April 2021
42. XIAO YJ, Dong X, Yang HZ, Tan HY, et al
    [Clinical features of 141 fatal cases of coronavirus disease in Jinyintan Hospital in Wuhan, China].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:354-359.
    PubMed     Abstract available
    
    
    March 2021
43. LI S, Liu SY, Zhao YQ, Li QY, et al
    [Spatial and temporal distribution and predictive value of chest CT scoring in patients with COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:230-236.
    PubMed     Abstract available
    
    
    January 2021
44. XU Y, Gao ZC
    [Interpretation of diagnosis and treatment for novel coronavirus pneumonia (Trial Eighth Edition)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:11-13.
    PubMed    
    
    
    
45. SHEN N, Liu BB, He B
    [Co-infection in Coronavirus disease and progress in antibiotic therapy].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:4-7.
    PubMed    
    
    
    December 2020
46. 
    [Antiviral therapy of COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:1096-1099.
    PubMed    
    
    
    
47. SHI LY, Cai YP, Zhang YX, Lin YL, et al
    [A comparison of clinical characteristics between patients with and without"recurrence"RNA positive with COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:1066-1070.
    PubMed     Abstract available
    
    
    November 2020
48. NIE NF, He Y
    [Potential therapeutic drugs for novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:970-974.
    PubMed     Abstract available
    
    
    October 2020
49. WANG X, Hu ZW, Hu Y, Cheng Y, et al
    [Comparison of severity classification of Chinese protocol, pneumonia severity index and CURB-65 in risk stratification and prognostic assessment of coronavirus disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:834-838.
    PubMed     Abstract available
    
    
    
50. 
    [Expert recommendations for the diagnosis and treatment of interstitial lung disease caused by novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:827-833.
    PubMed     Abstract available
    
    
    September 2020
51. 
    [Recommendation of respiratory rehabilitation for PICS in critically ill patients with COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:737-743.
    PubMed     Abstract available
    
    
    
52. ZHAN X, Liu B, Tong ZH
    [Postinflammatroy pulmonary fibrosis of COVID-19: the current status and perspective].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:728-732.
    PubMed     Abstract available
    
    
    
53. XIA JG, Li M, Zhan QY
    [Intervention timing of invasive mechanical ventilation and extracorporeal membrane oxygenation in the treatment of severe COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:725-728.
    PubMed    
    
    
    
54. PAN PH, Song C, Lu RL
    [The timing of continuous renal replacement therapy in severe COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:721-724.
    PubMed    
    
    
    
55. XIE LX, Xie SL
    [Immune imbalance and immunoregulatory treatment of COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:717-721.
    PubMed    
    
    
    August 2020
56. ZHU Q, Zhang W, Wang Q, Liu JH, et al
    [Clinical characteristics and outcome of 64 patients with severe COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:659-664.
    PubMed     Abstract available
    
    
    
57. ZENG YL, Zhang C, Gao F, Ma L, et al
    [Analysis of clinical characteristics of 49 cases of COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:654-658.
    PubMed     Abstract available
    
    
    
58. QIN W, Hu BZ, Zhang Z, Chen S, et al
    [Clinical characteristics and death risk factors of severe COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:648-653.
    PubMed     Abstract available
    
    
    June 2020
59. LU XF, Gong W, Wang L, Li L, et al
    [Clinical features and high resolution CT imaging evolution of coronavirus disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:509-515.
    PubMed     Abstract available
    
    
    
60. 
    [Guide for the prevention and treatment of coronavirus disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:473-489.
    PubMed     Abstract available
    
    
    May 2020
61. ZHANG SX, Li J, Zhou P, Na JR, et al
    [The analysis of clinical characteristics of 34 novel coronavirus pneumonia cases in Ningxia Hui autonomous region].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:431-436.
    PubMed     Abstract available
    
    
    
62. 
    [Diagnosis and Treatment Protocol for COVID-19 from Military Medical Team Supporting Wuhan (Trial Version 2)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:414-420.
    PubMed     Abstract available
    
    
    
63. ZHAO Q, He Y
    [Application of convalescent plasma therapy on novel coronavirus infection].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:409-413.
    PubMed     Abstract available
    
    
    April 2020
64. 
    [Expert consensus on sleep study and non-invasive positive airway pressure therapy during the epidemic of coronavirus disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E043.
    PubMed     Abstract available
    
    
    
65. SUN C, Zhang XB, Dai Y, Xu XZ, et al
    [Clinical analysis of 150 cases of 2019 novel coronavirus infection in Nanyang City, Henan Province].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E042.
    PubMed     Abstract available
    
    
    
66. LIU YJ, Yang YL, Xu Y
    [What we learned from SARS may provide important insights into understanding and management of coronavirus disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:339-344.
    PubMed     Abstract available
    
    
    
67. TAN FR, Qiu YL, Xu Z
    [Bronchoalveolar lavage fluid was used to diagnose two cases of 2019-nCoV infection].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:337-339.
    PubMed     Abstract available
    
    
    
68. 
    [Recommendations for respiratory rehabilitation of coronavirus disease 2019 in adult].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:308-314.
    PubMed     Abstract available
    
    
    
69. 
    [Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:288-296.
    PubMed     Abstract available
    
    
    
70. LI XY, Du B, Wang YS, Kang HYJ, et al
    [The keypoints in treatment of the critical coronavirus disease 2019 patient(2)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:277-281.
    PubMed     Abstract available
    
    
    
71. SHI Y
    [What are the highlights of "Diagnosis and treatment of disease 2019 novel coronavirus infection suitable for Military support Hubei medical team"].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:315-320.
    PubMed     Abstract available
    
    
    
72. QIU HB, Li XY, Du B, Kang HYJ, et al
    [The keypoints in treatment of the critical coronavirus disease 2019 patient(1)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:273-277.
    PubMed     Abstract available
    
    
    
73. ZHANG T, Sun LX, Feng RE
    [Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E040.
    PubMed     Abstract available
    
    
    March 2020
74. REN YH, Wang SY, Liu M, Guo YM, et al
    [When COVID-19 encounters interstitial lung disease: challenges and management].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E039.
    PubMed     Abstract available
    
    
    
75. LI HC, Ma J, Zhang H, Cheng Y, et al
    [Thoughts and practice on the treatment of severe and critical new coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E038.
    PubMed     Abstract available
    
    
    
76. SUN ML, Yang JM, Sun YP, Su GH, et al
    [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:219-222.
    PubMed     Abstract available
    
    
    
77. ZHANG MQ, Wang XH, Chen YL, Zhao KL, et al
    [Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:215-218.
    PubMed     Abstract available
    
    
    
78. CHEN L, Liu HG, Liu W, Liu J, et al
    [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:203-208.
    PubMed     Abstract available
    
    
    
79. 
    [Expert consensus for bronchoscopy during the epidemic of 2019 novel coronavirus infection (Trial version)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:199-202.
    PubMed     Abstract available
    
    
    
80. 
    [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:185-188.
    PubMed     Abstract available
    
    
    
81. ZHAO JP, Hu Y, Du RH, Chen ZS, et al
    [Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:183-184.
    PubMed    
    
    
    
82. YANG F, Liu N, Hu JY, Wu LL, et al
    [Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:180-182.
    PubMed     Abstract available
    
    
    
83. YUAN X, Mu JS, Mo GX, Hu XS, et al
    [Respiratory support for severe 2019-nCoV pneumonia suffering from acute respiratory failure: time and strategy].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:177-180.
    PubMed     Abstract available
    
    
    
84. DU B, Qiu HB, Zhan X, Wang YS, et al
    [Pharmacotherapeutics for the new coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:173-176.
    PubMed     Abstract available
    
    
    
85. LI H, Wang YM, Xu JY, Cao B, et al
    [Potential antiviral therapeutics for 2019 Novel Coronavirus].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:170-172.
    PubMed     Abstract available
    
    
    
86. ZHOU L, Liu HG
    [Early detection and disease assessment of patients with novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:167-170.
    PubMed     Abstract available
    
    
    
87. GAO ZC
    [Efficient management of novel coronavirus pneumonia by efficient prevention and control in scientific manner].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:163-166.
    PubMed     Abstract available
    
    
    
88. 
    [Medical management and prevention instruction of chronic obstructive pulmonary disease during the coronavirus disease 2019 epidemic].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E034.
    PubMed     Abstract available
    
    
    
89. TIAN XL, Peng M, Wang HP, Cai BQ, et al
    [The differential diagnosis for novel coronavirus pneumonia and similar lung diseases in general hospitals].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E035.
    PubMed     Abstract available
    
    
    
90. CAI SJ, Wu LL, Chen DF, Li YX, et al
    [Analysis of bronchoscope-guided tracheal intubation in 12 cases with COVID-19 under the personal protective equipment with positive pressure protective hood].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E033.
    PubMed     Abstract available
    
    
    
91. 
    [Expert consensus on Pulmonary Function Testing during the epidemic of Corona Virus Disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E032.
    PubMed     Abstract available
    
    
    
92. 
    [Expert recommendations on the management of patients with advanced non-small cell lung cancer during epidemic of COVID-19 (Trial version)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E031.
    PubMed     Abstract available
    
    
    
93. WU J, Feng CL, Xian XY, Qiang J, et al
    [Novel coronavirus pneumonia (COVID-19) CT distribution and sign features].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E030.
    PubMed     Abstract available
    
    
    
94. 
    [Recommendations for respiratory rehabilitation of COVID-19 in adult].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E029.
    PubMed     Abstract available
    
    
    
95. ZHOU L, Liu K, Liu HG
    [Cause analysis and treatment strategies of "recurrence" with novel coronavirus pneumonia (covid-19) patients after discharge from hospital].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E028.
    PubMed     Abstract available
    
    
    
96. CHENG JL, Huang C, Zhang GJ, Liu DW, et al
    [Epidemiological characteristics of novel coronavirus pneumonia in Henan].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E027.
    PubMed     Abstract available
    
    
    February 2020
97. LI XY, Du B, Wang YS, Kang HYJ, et al
    [The keypoints in treatment of the critical coronavirus disease 2019 patient].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E026.
    PubMed     Abstract available
    
    
    
98. LI YY, Wang WN, Lei Y, Zhang B, et al
    [Comparison of the clinical characteristics between RNA positive and negative patients clinically diagnosed with 2019 novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E023.
    PubMed     Abstract available
    
    
    
99. 
    [Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;17:E020.
    PubMed     Abstract available
    
    
    
100. 
     [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].
     Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E019.
     PubMed     Abstract available
     
     
     
101. SUN ML, Yang JM, Sun YP, Su GH, et al
     [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].
     Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E014.
     PubMed     Abstract available
     
     
     
102. DU B, Qiu HB, Zhan X, Wang YS, et al
     [Pharmacotherapeutics for the New Coronavirus Pneumonia].
     Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E012.
     PubMed     Abstract available
     
     
     
103. YUAN X, Mu JS, Mo GX, Hu XS, et al
     [Respiratory support for severe 2019-nCoV pneumonia suffering from acute respiratory failure: time and strategy].
     Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E010.
     PubMed     Abstract available
     
     
     
104. ZHAO JP, Hu Y, Du RH, Chen ZS, et al
     [Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia].
     Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E007.
     PubMed    
     
     
     
105. 
     [Expert consensus for bronchoscopy during the epidemic of 2019 Novel Coronavirus infection (Trial version)].
     Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E006.
     PubMed     Abstract available
     
     
     
106. CHEN L, Liu HG, Liu W, Liu J, et al
     [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].
     Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E005.
     PubMed     Abstract available
     
     
     
107. YANG F, Liu N, Wu JY, Hu LL, et al
     [Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV)].
     Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E004.
     PubMed     Abstract available
     
     
     
108. ZHOU L, Liu HG
     [Early detection and disease assessment of patients with novel coronavirus pneumonia].
     Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E003.
     PubMed     Abstract available
     
     
     
109. LI H, Wang YM, Xu JY, Cao B, et al
     [Potential antiviral therapeutics for 2019 Novel Coronavirus].
     Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E002.
     PubMed     Abstract available
     
     
     
110. GAO ZC
     [Efficient management of novel coronavirus pneumonia by efficient prevention and control in scientific manner].
     Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E001.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.